The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Nevakar competitive analysis

Loading summary...

Latest patents of Nevakar opposed by its competitors

Explore Nevakar's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3548000
Nov 10, 2021Atropine Pharmaceutical Compositions1

Latest PTAB cases involving Nevakar

Discover the latest PTAB cases involving Nevakar, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Nevakar

IPR2021-00442Mar 18, 2021NEVAKARSYDNEXISTerminated-Settled
IPR2021-00441Mar 3, 2021NEVAKARSYDNEXISTerminated-Settled
IPR2021-00440Feb 17, 2021NEVAKARSYDNEXISTerminated-Settled
IPR2021-00439Feb 3, 2021NEVAKARSYDNEXISTerminated-Settled
IPR2019-01446Aug 1, 2019NEVAKARCIPLATerminated

Peer Comparison New

IP litigation analysis comparing Nevakar with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEVAKAR - 15 -
CIPLA1166
PHARMA STULLN3 - - -
SYDNEXIS - - - 11